Analyst Ratings for Vanda Pharmaceuticals (VNDA)

VNDA Rating Summary

VNDA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on VNDA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.00 (+21%) * Over Last 12-Mos
Rating Score: 6.2 / 10   Percentile Rank: 62%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/25/2022 Jefferies Chris Howerton Downgrade Hold
(Buy)
12.00
(24.00)
13.07
(9.92)
-24.1% Details
5/12/2021 BofA Securities N/A New Coverage Buy
(N/A)
22.00
(N/A)
17.83
(9.92)
-44.36% Details